Drug-coated balloon versus conventional balloon for stent angioplasty in symptomatic intracranial atherosclerotic stenosis
Compared with CB predilation stent angioplasty, DCB predilation stent angioplasty effectively reduced the degree of restenosis and the risk of ISR, but had no advantage in terms of symptomatic restenosis risk currently. However, these findings should be interpreted cautiously because of the aforementioned limitations, and prospective multicenter randomized studies with larger patient number will be required to establish the efficacy and safety of DCB.
Authors
- Weili Li (ORCID: https://orcid.org/0000-0003-0886-7330)
- Ju Han (ORCID: https://orcid.org/0000-0002-8634-7536)
- Cunli Zhu (ORCID: https://orcid.org/0000-0002-7264-8004)
- Jun Zhang (ORCID: https://orcid.org/0000-0002-2613-3165)
- Yun Song (ORCID: https://orcid.org/0000-0001-6670-3807)
- L L Sun
- Chao Chen (ORCID: https://orcid.org/0000-0002-4422-1716)
- Yao Meng
- Meimei Zheng
- Hao Yin
- Wei Zhao
- Wei Wang
Institutions
- Shandong Provincial QianFoShan Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2026-01-07
- DOI
- https://doi.org/10.3389/fneur.2025.1686858
- Primary Topic
- Cerebrovascular and Carotid Artery Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00